PHARMACOKINETICS
& DYNAMICS IN
EARLY CLINICAL
DEVELOPMENT

Conference Date: 22 Nov 2010
Conference Ref: TD A11-1010
Fee: £425 + VAT
Venue: The Rembrandt Hotel, London

PART OF THE PHARMACOKINETICS & PHARMACODYNAMICS TRAINING DAYS 2010 -
3 new training days to deliver high quality training for restricted budgets

See also:
Drug Switchability & Population PK/PD – TD A11-1110 – 23rd November
Toxicology – TD A11-1210 – 24th November

Book 2 days at a discounted rate of £765 + VAT

Book all 3 days for only £1,085 + VAT

Why You Should Attend

In these sessions we will discuss what we can and should learn about pharmacokinetics and pharmacodynamics in the early clinical evaluation of drugs in development.  Examples of how pharmacodynamic measures can be used as biomarkers and surrogates of efficacy and safety will be presented.  The application of this information to assess benefit:risk and design dosing regimens in subsequent clinical trials will be demonstrated.

Who Should Attend

• Directors and staff of pharmaceutical companies, particularly those in:
• Clinical and Preclinical Research Departments
• Toxicology and Drug Safety
• Regulatory Affairs, Registration, Licensing
• Product Managers
• All those interested in early clinical drug evaluation.

This seminar is NOT aimed at the expert clinical pharmacologist.

Trainer: Dr John Posner PhD, FRCP, FFPM, Consultant in Drug Development

Click here to book your place